NCT06445816

Brief Summary

Resilience is defined as generating coping strategies for the problems and situations that individuals face throughout their lives and developing these strategies in each new situation. While some individuals become helpless in the face of difficulties and give up the struggle, other individuals recover quickly in the face of difficulties and use coping methods well. Accordingly, these individuals have higher levels of crisis management and coping with stress.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2023

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

May 23, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 6, 2024

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

June 6, 2024

Status Verified

June 1, 2024

Enrollment Period

1.2 years

First QC Date

May 23, 2024

Last Update Submit

June 5, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Psychological resilience scale

    The pain level of the child receiving chemotherapy will reduce the psychological resilience of the mother. In the schematic evaluation, the scoring method is free for measuring psychological resilience as high or low.

    2 day

Interventions

* Parents whose consent was obtained will be asked to fill out the Mother and Child Information Collection Form and Psychological Resilience Scale, respectively. * Immediately after receiving chemotherapy, the pain levels of the children will be measured with the Facial Expressions Pain Scale - Faces Pain Scale-Revised (FPS-R). * The psychological resilience scale will be applied to mothers.

Eligibility Criteria

Age4 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The study will consist of children between the ages of 4-18 and their parents who are being treated at the Oncology Clinic of Altınbaş University Medical Park Bahçelievler Hospital in Istanbul.

You may qualify if:

  • Children will be between 4-18 years old
  • Communicable children and families
  • The child will be hospitalized for inpatient treatment

You may not qualify if:

  • Outpatients
  • Terminal patients
  • Children whose parents cannot be reached will be excluded from work

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Gelisim University

Istanbul, Avcılar, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain

Interventions

Drug Therapy

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Ebru Sevinç

    Arel University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
2 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 23, 2024

First Posted

June 6, 2024

Study Start

May 1, 2023

Primary Completion

July 1, 2024

Study Completion

July 1, 2024

Last Updated

June 6, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations